AbbVie Inc. — Director's Dealing 2017

Mar 10, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2017-03-08

Reporting Person: GONZALEZ RICHARD A (Director, Chairman of the Board and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-08	Common stock, $0.01 par value	M	18366	$24.2082	Acquired	369113	Direct
2017-03-08	Common stock, $0.01 par value	M	53650	$29.2265	Acquired	422763	Direct
2017-03-08	Common stock, $0.01 par value	S	72016	$64.25	Disposed	350747	Direct
2017-03-10	Common stock, $0.01 par value	G	785	—	Disposed	349962	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-08	Option (right to buy)	$24.2082	M	18366	Disposed	2021-02-17	Common stock (18366)	Direct
2017-03-08	Option (right to buy)	$29.2265	M	53650	Disposed	2022-02-22	Common stock (53650)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.01 par value	4600	Indirect
Common stock, $0.01 par value	450	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these securities.

F2: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.